Role of podocyte B7-1 in diabetic nephropathy - Wikidata - awgldk - TriplyDB

Role of podocyte B7-1 in diabetic nephropathy

Role of podocyte B7-1 in diabetic nephropathy

http://www.wikidata.org/entity/Q33814864

about

FSGS: Diagnosis and Diagnostic Work-Up Podocytes A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications Kidney disease: new technologies translate mechanisms to cure Therapy: New data do not support use of abatacept in diabetic nephropathy.Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.Diabetic nephropathy - complications and treatment.Diabetes mellitus: The epidemic of the century.Knockout of the TauT gene predisposes C57BL/6 mice to streptozotocin-induced diabetic nephropathy.Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.Counting glomeruli and podocytes: rationale and methodologies.The Role of Bone Marrow Cells in the Phenotypic Changes Associated with Diabetic Nephropathy Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.Reversal of Early Diabetic Nephropathy by Islet Transplantation under the Kidney Capsule in a Rat Model.Tubular B7-1 expression parallels proteinuria levels, but not clinical outcomes in adult minimal change disease patients.Interleukin-20 targets podocytes and is upregulated in experimental murine diabetic nephropathy.Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy.How many Achilles' heels does a podocyte have? An update on podocyte biology.Diabetes mellitus in the transplanted kidney.The dark side of extracellular ATP in kidney diseases Designing drugs that combat kidney damage.Developing therapeutic 'arrows' with the precision of William Tell: the time has come for targeted therapies in kidney disease.The exciting "bench to bedside" journey of cell therapies for acute kidney injury and renal transplantation.CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease.Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease.The next generation of therapeutics for chronic kidney disease Increased urinary CD80 excretion and podocyturia in Fabry disease.High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial Cells.B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.Podocyte Expression of B7-1/CD80: Is it a Reliable Biomarker for the Treatment of Proteinuric Kidney Diseases with Abatacept?Valproate hampers podocyte acquisition of immune phenotypes via intercepting the GSK3β facilitated NFkB activation.Proteomic and metabolomic characterization of streptozotocin-induced diabetic nephropathy in TIMP3-deficient mice.Interaction of CD80 with Neph1: a potential mechanism of podocyte injury.Montelukast improves the changes of cytoskeletal and adaptor proteins of human podocytes by interleukin-13.Dichotomous roles of co-stimulatory molecules in diabetes mellitus.Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome.Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?

P2860

Q26744558-F55BF2F8-E79F-4F00-B246-B5F8C555FBF5 Q26766118-C7554726-6541-4FD1-A72C-4BBAE0F7D069 Q26769678-F2F84D37-080F-4432-90C5-02063FADB761 Q26825227-2913EF25-DA94-423B-94B7-7D62ECABA0B2 Q31023551-22249354-5367-4F35-B560-7DD75D13358D Q33741426-DF56B1C9-F733-48AC-92E9-75185E1D97E2 Q34387952-D8841026-FBCA-4194-A89D-6E299B91583B Q34671155-D52BE243-1C29-46ED-850C-64C1D5DC0ED1 Q35023913-56B9BF87-1098-4641-993A-12997259CA50 Q35499717-2007B2A3-503C-4DF0-B40F-E1484874C369 Q35738542-2A139AC1-72D0-4D22-9C81-DBDB76EC32FC Q35764838-D4E0A672-EAFA-4A82-8C52-70EBBF6740F4 Q35982758-5F79111A-619E-490D-ACDA-75165EFDB0EB Q36070420-042210B7-F034-4AB9-9761-9F2CA84960CC Q36746102-2470B332-21B3-4E13-A19C-BF5CB57902DC Q36908288-3BF91550-4E2F-4597-A6B9-F1A94D36745A Q37306789-811C2006-3A59-44BE-A050-9A509F67F1B8 Q37620681-C17C1074-2F70-464C-90D7-BD7885096665 Q37739475-3C9E7EDC-7B57-406E-B437-93461583DA35 Q38217417-CDF79C2C-B797-424B-AE16-F1E09E377595 Q38217483-52F8E5C9-E04F-42F0-ABE9-735E7911711C Q38249183-CFFD801A-E58F-4120-99F5-DA831E311CA8 Q38276349-410ACB3F-9EA0-43C2-A6AB-6BA3AA0184FD Q38404587-242A3EF3-C85D-4553-902E-C4DE84F0D2CD Q38518588-9CBA6D2A-BBA2-49CB-852D-A87E1F445A31 Q38558079-4D51D06B-AE04-4653-A38D-6B08DE193CB1 Q38593433-1CD90AB6-A6AB-46B5-A959-25C3E21E3EF8 Q38756737-C01D8C2B-65BE-4449-AFC7-4FC6CB1A04D2 Q38845590-0FCCEF51-52C0-4F0F-A0FB-AC36635E436A Q41452180-7A26067E-8F57-49A0-87E3-66588AA15BF4 Q41856193-7B490F54-49EA-4265-9183-26040680A7A0 Q42371173-45D0048B-FEB8-4434-BAE5-1B1C1538705A Q42925631-FB341656-2698-4C26-B806-4F78AB329715 Q45385733-E5BBC9B1-8E87-4AFB-B600-A67926576F2A Q47406292-BE9ADE7E-2EF1-4338-972E-267A8E4DD573 Q47664775-B412E478-8930-4EFD-BD41-7BFEC63C2B3E Q48288285-2AD888C5-40FF-4AA4-B8ED-ABB6B26E7564 Q49519207-EDE6E7C8-F419-4505-859B-BDC168F7AD14 Q49772713-C820883D-D392-4E16-9AEF-6ADA9416C00A Q50856119-BE85C6DD-1CE6-44BC-9D90-43F5B5A68421

P2860

Role of podocyte B7-1 in diabetic nephropathy

http://www.wikidata.org/entity/Q33814864

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Role of podocyte B7-1 in diabetic nephropathy

@ast

Role of podocyte B7-1 in diabetic nephropathy

@en

type

label

Role of podocyte B7-1 in diabetic nephropathy

@ast

Role of podocyte B7-1 in diabetic nephropathy

@en

prefLabel

Role of podocyte B7-1 in diabetic nephropathy

@ast

Role of podocyte B7-1 in diabetic nephropathy

@en

P1433

Q33814864-2CD276F7-C6FB-4305-B78E-431920329B3F

P1476

Q33814864-85822F83-1D01-419B-B22D-A468945483B0

P2093

Q33814864-0744779F-C2BF-4D1A-91CF-3C3621C77CD3

Q33814864-0B793323-553B-42E9-B387-7F8AF16B57A0

Q33814864-17A47011-FAF7-419A-AFAF-C262B5B8B893

Q33814864-2AA101F0-9124-482D-AC1F-0D0528564839

Q33814864-4296457E-E3B1-44C1-9FBF-DB9362FD0C60

Q33814864-5737505E-421E-423C-B898-773FA1DCE15A

Q33814864-6198A045-1949-407F-914E-A0C0CF11DF9E

Q33814864-67BD4ADF-EF24-44B7-B72D-C201552B1C75

Q33814864-6C0CB9EC-BF10-4B85-8EFC-C2ADEFCA0523

Q33814864-6DE37044-6176-4F2F-B71C-B1C2A47A5738

P2860

Q33814864-06679A96-68D1-4DCA-BB64-62D3CD322C15

Q33814864-12DD4D48-108B-4AD6-9F1B-0AD47718E1A6

Q33814864-1DB05872-ACD6-4A61-883C-34D8DCC84486

Q33814864-2B03CC6B-5432-41CA-85F3-AD4DDD62FFDC

Q33814864-2D9BCE52-EA91-4E64-9A4F-5AE0B68D3C52

Q33814864-35900D10-451D-42B3-9D13-8CD7A9F1649C

Q33814864-3A5185B7-94DE-4662-8BE2-D921D551F446

Q33814864-3A8A01AA-9575-4A07-85A0-94CDA3DA7FED

Q33814864-3D8E96B0-3E10-4653-91B9-C0A35205C1E9

Q33814864-429D1FB6-47E9-437B-AB06-6410E6214EAA

P304

Q33814864-A1ED82A1-41AD-4A26-B770-5AA869C28A5D

P31

Q33814864-2C205300-154D-4E70-B411-78831929EDB7

P356

Q33814864-0F2926E4-46ED-494C-B376-006E3649DB08

P433

Q33814864-A2BB6FE9-8A63-447B-A8D2-ADE0C90D8954

P478

Q33814864-2D48C463-6AD6-467A-B3ED-92C910EBC5DC

P50

Q33814864-15AD50DD-574C-4350-9B0C-5CCE3CEDE00F

Q33814864-17AAC791-D852-4658-8725-46DEC6879F3B

Q33814864-1DAB0B5F-B6EA-447E-B63A-088238024E29

Q33814864-3B2A7A05-8F2D-45F2-B707-F4932F639BDA

Q33814864-55D302E6-ABE6-4EF6-A123-239AC72531CC

Q33814864-6C03C35D-F476-468B-847A-6AB2E11469EB

Q33814864-DB2C9CB7-3055-4521-B8E1-D737C61B3C8C

Q33814864-E732FC3E-7B6E-43D5-9FFD-5A51AEC9F9F9

P577

Q33814864-C17C4031-01AD-4304-830A-A6BFA1337A47

P5875

Q33814864-84C9634E-7CAA-4460-AD6C-D559F766F3A5

P698

Q33814864-33B2D3CE-C7B0-436F-ACEA-0CB6C110098C

P932

Q33814864-1F7EC8AB-002F-465D-9A8B-F8D7AD7C418B

P356

P1433

Journal of the American Society of Nephrology

P1476

Role of podocyte B7-1 in diabetic nephropathy

@en

P2093

Andrea Vergani

http://www.w3.org/2001/XMLSchema#string

Andrzej S Krolewski

http://www.w3.org/2001/XMLSchema#string

Chih-Chuan Yu

http://www.w3.org/2001/XMLSchema#string

Deborah Mattinzoli

http://www.w3.org/2001/XMLSchema#string

Flavio Vincenti

http://www.w3.org/2001/XMLSchema#string

Giovanna Finzi

http://www.w3.org/2001/XMLSchema#string

Jer-Ming Chang

http://www.w3.org/2001/XMLSchema#string

Jochen Reiser

http://www.w3.org/2001/XMLSchema#string

Marcus G Pezzolesi

http://www.w3.org/2001/XMLSchema#string

Maria Pia Rastaldi

http://www.w3.org/2001/XMLSchema#string

P2860

Pentoxifylline for diabetic kidney disease

PLINK: a tool set for whole-genome association and population-based linkage analyses

Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes

The B7 family revisited

Paxillin: a focal adhesion-associated adaptor protein.

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy.

An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes.

Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes.

Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation.

Nephropathy in patients with type 2 diabetes mellitus.

P304

1415-1429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2013050518

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Mehmet M. Altintas

Stefano La Rosa

Francesca D'Addio

Domenico Corradi

P577

2014-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261187813

http://www.w3.org/2001/XMLSchema#string

P698

24676639

http://www.w3.org/2001/XMLSchema#string

P932

4073425

http://www.w3.org/2001/XMLSchema#string